A comment on the International Society of Geriatric Oncology guidelines: evidence-based advice for the clinical setting.
Standard
A comment on the International Society of Geriatric Oncology guidelines: evidence-based advice for the clinical setting. / Fitzpatrick, John M; Graefen, Markus; Payne, Heather A; Scotté, Florian; Aapro, Matti S.
in: ONCOLOGIST, Jahrgang 17 Suppl 1, 2012, S. 31-35.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - A comment on the International Society of Geriatric Oncology guidelines: evidence-based advice for the clinical setting.
AU - Fitzpatrick, John M
AU - Graefen, Markus
AU - Payne, Heather A
AU - Scotté, Florian
AU - Aapro, Matti S
PY - 2012
Y1 - 2012
N2 - Largely a disease of older men, prostate cancer is likely to become a growing burden in the developed world as the population ages and overall life expectancy increases. Furthermore, prostate cancer management in older men is not optimal, reflecting the lack of training dedicated to senior adults in fellowship programs and the lack of specific guidelines to manage senior adults. The International Society of Geriatric Oncology (SIOG) convened a multidisciplinary Prostate Cancer Working Group to review the evidence base and provide advice on the management of the disease in senior age groups. The Working Group reported that advancing age, by itself, is not a reliable guide to treatment decision making for men with either localized or advanced prostate cancer. Instead, the SIOG guidelines advise health care teams to assess the patient's underlying health status, which is largely dictated by associated comorbid conditions, but also by dependency in activities of daily living and nutritional status, and to use the findings to categorize the individual into one of four groups: healthy, vulnerable, frail, or terminally ill. The guidelines recommend that a patient categorized as healthy or vulnerable (i.e., with reversible problems following geriatric intervention) should receive the same approach to treatment as a younger patient. Frail patients should be managed using adapted treatment strategies, and the terminally ill should receive symptomatic/palliative care only. The guidelines may have ongoing relevance as the treatment options for prostate cancer expand.
AB - Largely a disease of older men, prostate cancer is likely to become a growing burden in the developed world as the population ages and overall life expectancy increases. Furthermore, prostate cancer management in older men is not optimal, reflecting the lack of training dedicated to senior adults in fellowship programs and the lack of specific guidelines to manage senior adults. The International Society of Geriatric Oncology (SIOG) convened a multidisciplinary Prostate Cancer Working Group to review the evidence base and provide advice on the management of the disease in senior age groups. The Working Group reported that advancing age, by itself, is not a reliable guide to treatment decision making for men with either localized or advanced prostate cancer. Instead, the SIOG guidelines advise health care teams to assess the patient's underlying health status, which is largely dictated by associated comorbid conditions, but also by dependency in activities of daily living and nutritional status, and to use the findings to categorize the individual into one of four groups: healthy, vulnerable, frail, or terminally ill. The guidelines recommend that a patient categorized as healthy or vulnerable (i.e., with reversible problems following geriatric intervention) should receive the same approach to treatment as a younger patient. Frail patients should be managed using adapted treatment strategies, and the terminally ill should receive symptomatic/palliative care only. The guidelines may have ongoing relevance as the treatment options for prostate cancer expand.
KW - Humans
KW - Male
KW - Aged
KW - Practice Guidelines as Topic
KW - Activities of Daily Living
KW - Health Status
KW - Life Expectancy
KW - Geriatrics
KW - Decision Making
KW - Palliative Care/methods
KW - Geriatric Assessment/methods
KW - Evidence-Based Medicine
KW - Prostatic Neoplasms/epidemiology/therapy
KW - Humans
KW - Male
KW - Aged
KW - Practice Guidelines as Topic
KW - Activities of Daily Living
KW - Health Status
KW - Life Expectancy
KW - Geriatrics
KW - Decision Making
KW - Palliative Care/methods
KW - Geriatric Assessment/methods
KW - Evidence-Based Medicine
KW - Prostatic Neoplasms/epidemiology/therapy
M3 - SCORING: Journal article
VL - 17 Suppl 1
SP - 31
EP - 35
JO - ONCOLOGIST
JF - ONCOLOGIST
SN - 1083-7159
ER -
